JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.23B |
| 2 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
+$438M |
| 3 |
Royal Caribbean
RCL
|
+$434M |
| 4 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$432M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$424M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.08B |
| 2 |
Meta Platforms (Facebook)
META
|
+$722M |
| 3 |
CB
CHUBB CORPORATION
CB
|
+$721M |
| 4 |
Apple
AAPL
|
+$701M |
| 5 |
Netflix
NFLX
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 21.51% |
| 2 | Financials | 13.49% |
| 3 | Technology | 11.69% |
| 4 | Healthcare | 10.22% |
| 5 | Consumer Discretionary | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3301
Rocket Pharmaceuticals
RCKT
$277M
| $325K | ﹤0.01% |
+10,987
| New | +$330K |
2016 Q1
0 quarters
|
|
|
SFR
3302
DELISTED
Starwood Waypoint Homes
SFR
| $325K | ﹤0.01% |
13,139
+2,410
| +22% | +$53.9K |
2015 Q4
1 quarter
|
|
|
AXAS
3303
DELISTED
Abraxas Petroleum Corp
AXAS
| $324K | ﹤0.01% |
16,045
-1,045
| -6% | -$20.4K |
2014 Q2
7 quarters
|
|
|
MBTF
3304
DELISTED
MBT Financial Corporation
MBTF
| $322K | ﹤0.01% |
+39,953
| New | +$309K |
2016 Q1
0 quarters
|
|
3305
CALL
Lumen
LUMN
$5.81B
| $320K | ﹤0.01% |
10,000
| – | – |
2015 Q4
1 quarter
|
|
|
MODV
3306
DELISTED
ModivCare
MODV
| $320K | ﹤0.01% |
6,275
-718
| -10% | -$33.6K |
2015 Q4
1 quarter
|
|
3307
iShares MSCI EAFE Value ETF
EFV
$30.7B
| $319K | ﹤0.01% |
7,114
-386
| -5% | -$16.7K |
2014 Q3
6 quarters
|
|
3308
iShares MSCI USA Momentum Factor ETF
MTUM
$20.8B
| $319K | ﹤0.01% |
4,362
-6,627
| -60% | -$463K |
2015 Q1
4 quarters
|
|
3309
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$416M
| $318K | ﹤0.01% |
9,184
-5,595
| -38% | -$185K |
2013 Q3
10 quarters
|
|
3310
Vanguard World Funds Extended Duration ETF
EDV
$3.37B
| $318K | ﹤0.01% |
2,505
-13,125
| -84% | -$1.63M |
2014 Q4
5 quarters
|
|
|
RTEC
3311
DELISTED
Rudolph Technologies Inc
RTEC
| $318K | ﹤0.01% |
23,275
-2,275
| -9% | -$28.7K |
2015 Q3
2 quarters
|
|
|
AVNU
3312
DELISTED
AVENUE FINL HLDGS INC COM STK (TN)
AVNU
| $318K | ﹤0.01% |
+16,427
| New | +$281K |
2016 Q1
0 quarters
|
|
3313
Invesco Zacks Multi-Asset Income ETF
CVY
$118M
| $317K | ﹤0.01% |
17,138
-9,428
| -35% | -$166K |
2014 Q4
5 quarters
|
|
3314
Invesco S&P MidCap 400 Pure Growth ETF
RFG
$342M
| $314K | ﹤0.01% |
12,955
+410
| +3% | +$9.43K |
2013 Q3
10 quarters
|
|
|
JMG
3315
DELISTED
JOURNAL MEDIA GROUP INC COM
JMG
| $314K | ﹤0.01% |
26,202
-152,440
| -85% | -$1.83M |
2015 Q2
3 quarters
|
|
3316
Intrepid Potash
IPI
$447M
| $313K | ﹤0.01% |
28,145
-102,280
| -78% | -$1.85M |
2013 Q2
11 quarters
|
|
3317
BlackBerry
BB
$5.64B
| $312K | ﹤0.01% |
38,553
-15,121
| -28% | -$113K |
2013 Q2
11 quarters
|
|
|
OREX
3318
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $311K | ﹤0.01% |
55,273
+2,573
| +5% | +$33.4K |
2013 Q2
11 quarters
|
|
3319
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
$3.1B
| $310K | ﹤0.01% |
5,710
-1,536
| -21% | -$83.4K |
2013 Q2
11 quarters
|
|
3320
Capitol Federal Financial
CFFN
$1.05B
| $309K | ﹤0.01% |
23,338
+2,263
| +11% | +$28.2K |
2013 Q2
11 quarters
|
|
|
TRVN
3321
DELISTED
Trevena, Inc.
TRVN
| $309K | ﹤0.01% |
60
| – | – |
2015 Q4
1 quarter
|
|
3322
PUT
Applied Materials
AMAT
$424B
| $307K | ﹤0.01% |
14,500
-200
| -1% | -$3.65K |
2014 Q3
6 quarters
|
|
3323
Zevra Therapeutics
ZVRA
$621M
| $307K | ﹤0.01% |
+1,323
| New | +$320K |
2016 Q1
0 quarters
|
|
3324
Lindblad Expeditions
LIND
$2.37B
| $304K | ﹤0.01% |
+30,609
| New | +$309K |
2016 Q1
0 quarters
|
|
|
AIV.PRA
3325
DELISTED
Apart. Invst and Mgt Co
AIV.PRA
| $304K | ﹤0.01% |
11,109
+6,509
| +142% | +$171K |
2015 Q2
3 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2016 Portfolio in Review
As of Q1 2016, JP Morgan Chase held 5,307 positions worth $391B, down 1.9% from $398B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2016 filing shows 536 new, 1,742 increased, 1,913 reduced and 585 closed positions. Its largest new stake was JPMorgan Diversified Return Europe Equity ETF: 519,787 shares worth $26.6M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $1.08B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 20% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q1 2016 buy was JPMorgan Diversified Return Europe Equity ETF: 519,787 shares worth $26.6M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q1 2016, an estimated $2.23B increase.
- JP Morgan Chase's biggest Q1 2016 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $1.08B.
- JP Morgan Chase fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $721M.
- JP Morgan Chase's ten largest holdings make up 17% of its $391B portfolio in Q1 2016.
- JP Morgan Chase opened 536 new positions and closed 585 in Q1 2016.
- JP Morgan Chase's portfolio value fell 1.9% quarter-over-quarter to $391B.
Based on JP Morgan Chase's 13F filing for Q1 2016, filed 10 May 2016.